3 reports of this reaction
3.4% of all LEVOTHYROXINE, LIOTHYRONINE reports
#4 most reported adverse reaction
DIZZINESS is the #4 most commonly reported adverse reaction for LEVOTHYROXINE, LIOTHYRONINE, manufactured by Acella Pharmaceuticals, LLC. There are 3 FDA adverse event reports linking LEVOTHYROXINE, LIOTHYRONINE to DIZZINESS. This represents approximately 3.4% of all 87 adverse event reports for this drug.
Patients taking LEVOTHYROXINE, LIOTHYRONINE who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is moderately reported among LEVOTHYROXINE, LIOTHYRONINE users, representing a notable but not dominant share of adverse events.
In addition to dizziness, the following adverse reactions have been reported for LEVOTHYROXINE, LIOTHYRONINE:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 3 FDA reports for LEVOTHYROXINE, LIOTHYRONINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 3.4% of all adverse event reports for LEVOTHYROXINE, LIOTHYRONINE, making it a notable side effect.
If you experience dizziness while taking LEVOTHYROXINE, LIOTHYRONINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.